The Impact of Philanthropy
Moffitt Cancer Center Foundation Annual Report – January 2019
Together with our donors, we reached an impressive milestone in 2018 - the Moffitt Foundation has experienced its most successful fundraising year to-date! Our community of more than 22,000 donors combined raised more than $30 million for patient care, cancer research, education and community outreach efforts.
Community Fundraising Events
More than 80 events were hosted by dedicated local and statewide community partners that, together, raised more than $1.6 million for Moffitt. All community events were instrumental in raising funds to support Moffitt’s mission.
25th Annual Magnolia Ball
In just one evening, more than 600 guests raised $2.7 million to benefit cancer research, education and patient care. Moffitt champions Les and Pam Muma chaired the 2018 ball, while The Beach Boys rocked the crowd. The Magnolia Ball has become a remarkable event, raising more than $42 million total over the past 25 years.
Save the Date for The 26th Annual Magnolia Ball: Saturday, April 27, 2019 at the Marriott Waterside Hotel. 2019 Chairs: Lesa France Kennedy and Bill Christy
Miles for Moffitt. New Beginnings
After 12 years of hosting the annual Miles for Moffitt event on the University of South Florida campus, Moffitt was excited to start a new chapter on December 8. Miles for Moffitt officially moved to its new, permanent location in downtown Tampa. The 2018 Race hosted 6,000 runners with over $1 million raised.
Online advancements for easier access for our donors
As part of our commitment to you, this year the Moffitt Foundation launched new and improved websites to enhance your donor experience. Now it is easier than ever to get involved with Moffitt and help save lives today: Moffitt.org/Give is your main hub for all things philanthropy.
Moffitt is No. 8 on the U.S. News & World Report Best Hospitals for Cancer List
The ranking, up from No. 9 last year, solidifies Moffitt as the best cancer hospital in Florida and top-ranked in the Southeast. Moffitt has been included in the annual Best Hospitals list since 1999 and ranked in the top 10 the past three years. This is among several national distinctions Moffitt was recognized for in 2018, including:
- Only National Cancer Institute-designated Comprehensive Cancer Center based in Florida
- CEO Cancer Gold Standard accreditation for the 10th year in a row
- 4 on DiversityInc’s 2018 Top Hospitals & Health Systems list
- Tampa Bay Times Top Workplaces in 2018
- Leader in LGBTQ Healthcare Equality
- Magnet Recognized by the American Nurses Credentialing Center
Curing the Incurable – CAR T Therapy
From a basic idea of training one’s own immune system to attack the disease, the biggest medical science breakthrough of 2017 emerged – CAR T therapy. Moffitt oncologist Dr. Frederick Locke served as the co-lead investigator for the clinical trials that led to the approval of Yescarta, one of two approved CAR T therapies.
Moffitt’s Centers of Excellence
Moffitt is proud to have four Centers of Excellence that build upon our research strengths where each addresses an important cancer problem in Florida and beyond.
Lung Cancer Center of Excellence (LCCoE)
LCCoE investigators are using advanced technology to gain valuable insights into how the disease may grow, evade attack by the immune system and spread to other vital organs.
Dianne Durst - Because of your support, our physicians are able to provide many patients like Dianne – who originally thought they were out of options – with life changing, cutting-edge treatments.
The MSCRCoE was established to be a leading contributor to the prevention and cure of melanoma and other skin cancers. The efforts of Moffitt’s researchers have led to the accelerated development of immunological therapeutics, novel prevention strategies and targeted therapies. Moffitt clinicians have enrolled more than 1,500 patients into cutting-edge clinical trials, establishing the program as a prominent leader in industry research.
Moffitt is using mathematical modeling, sophisticated diagnostics and evolutionary principles to create personalized treatment plans for patients. We are designing a new generation of protocols that actively integrate evolutionary principles to delay or even prevent resistance. This allows us to extend our patients’ lives and ensure a better quality of life.
The purpose of the CIIRC is to reveal the role of infectious agents in the origin of cancer and translate this knowledge into new and more effective strategies for the prevention and treatment of cancer.
We could not do what we do without philanthropic support from you - our community of donors. Whether you are an individual, family organization, foundation, business, or community partner, you are making an impact on the fight against cancer. Our accomplishments are only made possible through your generosity and commitment to our mission: to contribute to the prevention and cure of cancer.